Sponsor by Innity

Sponsor by cwyeoh

Sponsor by Nuffnang

Monday, April 2, 2012

KLCI Stock - TSH / 9059 - 2011 Quarter 4

Company Info
Market Capital (Capital Size)1,892,287,973 (Large)
Par ValueRM 0.50

My Analysis
Forecast P/E now(2.29-0.035)/0.174 = 12.96 (Moderate)
Target Price2.44+0.035 = 2.47 (PE 14.0, EPS 0.174, DPS 0.035)
DecisionBUY if MACD start moving uptrend while stock price is above 2.25 or wait MACD start moving up from another low price
Comment
Revenue increased 7.2% and also higher than preceding year corresponding quarter 19%, eps decreased 46.2% and was second consecutive quarter decreasing and also lower than preceding year corresponding quarter 15.3%, cash generated from operating enough to cover financing expenses but not for investing expenses hence spent 20.1% of Group cash to cover, gross profit still very high, slightly improved liquidity ratio but still at weak level now, higher gearing ratio at high level now, debt ratio getting near to historical high, all accounting ratio are good, benefit from CPO price uptrend
First Support Price2.26
Second Support Price2.12
Risk RatingMODERATE

Research House
AMMB Target Price1.14 (2011-02-16)
HLG Target Price2.23 (2012-02-23)
HwangDBS Target Price2.55 (2012-02-23)
Maybank Target Price2.5 (2012-02-23)
MIDF Target Price2.83 (2012-02-23)
OSK Target Price2.65 (2012-02-23)
Jupiter Target Price2.88 (2012-02-27)

Accounting Ratio
Return on Equity12.69%
Dividend Yield1.53%
Gross Profit Margin25.48%
Operating Profit Margin10.89%
Net Profit Margin10.26%
Tax Rate11.21%
Asset Turnover0.5797
Net Asset Value Per Share1.04
Net Tangible Asset per share0.98
Price/Net Tangible Asset Per Share2.19
Cash Per Share0.08
Liquidity Current Ratio0.7314
Liquidity Quick Ratio0.4036
Liquidity Cash Ratio0.1178
Gearing Debt to Equity Ratio1.2133
Gearing Debt to Asset Ratio0.5207
Working capital per thousand Ringgit sale-13.2%
Days to sell the inventory80
Days to collect the receivables44
Days to pay the payables57

Technical Analysis
SMA 202.272 (Uptrend 15 days)
SMA 502.174 (Uptrend)
SMA 1001.976 (Uptrend)
SMA 2001.537 (Uptrend)
MACD (26d/12d)0.035137 ( 0.002364 )
Signal (9)0.043372 ( 0.002059 )
MACD Histogram0.008235 (Bearish trend 7 days)

My notes based on 2011 quarter 4 report (number in '000):-
- Lower pbt mainly due to lower profit contribution from jointly controlled entities coupled with higher foreign exchange losses, provision of doubtful debts in Wood Products segment

- Higher revenue due mainly to higher capacity utilisation of processing plants in Palm and Bio-Integration business segment

- Estimate next 4Q eps after 2011 Q4 result announced = 949709*0.15/818617 = 0.174, estimate PE on current price 2.29 = 12.96(DPS 0.035)
- Estimate next 4Q eps after 2011 Q3 result announced = 0.0841*4/2 = 0.1682, estimate highest/lowest PE = 13.32/10.49 (DPS 0.03)
- Estimate next 4Q eps after 2011 Q2 result announced = 0.0876*4*0.9 = 0.3154, estimate highest/lowest PE = 12.18/8.56 (DPS 0.06)
- Estimate next 4Q eps after 2011 Q1 result announced = 0.0583*4*0.9 = 0.2099, estimate highest/lowest PE = 15.2/13.29 (DPS 0.06)
- Estimate next 4Q eps after 2010 Q4 result announced = 0.2068*4*1.2 = 0.2482, estimate highest/lowest PE = 11.2/10.44 (DPS 0.06)
- Estimate next 4Q eps after 2010 Q3 result announced = 0.0444*4*1.1 = 0.1954, estimate highest/lowest PE = 14.84/11.41 (DPS 0.05)
- Estimate next 4Q eps after 2010 Q2 result announced = 0.033*4 = 0.132, estimate highest/lowest PE = 21.21/13.94 (DPS 0.05)
- Estimate next 4Q eps after 2010 Q1 result announced = 0.1938*0.95 = 0.1841, estimate highest/lowest PE = 10.59/8.8 (DPS 0.05)
- Estimate next 4Q eps after 2009 Q4 result announced = 0.1802*1.1 = 0.1982, estimate highest/lowest PE = 10.65/8.78 (DPS 0.05)
- Estimate next 4Q eps after 2009 Q3 result announced = 0.0568*4*0.95 = 0.2158, estimate highest/lowest PE = 10.66/7.92 (DPS 0.05)
- Estimate next 4Q eps after 2009 Q2 result announced = 0.055*4*0.8 = 0.176, estimate highest/lowest PE = 10.97/8.35 (DPS 0.05)

TSH latest news (English)

TSH latest news (Chinese)

No comments:

Post a Comment